Telitacicept as double-targeted therapy for myasthenia gravis coexisting with connective tissue disease: three case reports
Myasthenia gravis (MG) and connective tissue diseases (CTD) are both B-cell-mediated, antibody-associated autoimmune diseases that share similar mechanisms of immune dysfunction. The coexistence of MG and CTD is a rare phenomenon, and its management re…